2‐Arachidonoyl‐glycerol‐ and arachidonic acid‐stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV‐1, and RSV. Issue 2 (1st February 2013)
- Record Type:
- Journal Article
- Title:
- 2‐Arachidonoyl‐glycerol‐ and arachidonic acid‐stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV‐1, and RSV. Issue 2 (1st February 2013)
- Main Title:
- 2‐Arachidonoyl‐glycerol‐ and arachidonic acid‐stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV‐1, and RSV
- Authors:
- Chouinard, François
Turcotte, Caroline
Guan, Xiaochun
Larose, Marie‐Chantal
Poirier, Samuel
Bouchard, Line
Provost, Véronique
Flamand, Louis
Grandvaux, Nathalie
Flamand, Nicolas - Abstract:
- Abstract : Neutrophils activated with nanomolar concentrations of 2‐arachidonoyl‐glycerol or arachidonic acid, release antimicrobial effectors, unraveling these lipids as possible regulators of host defense in vivo. Abstract : The endocannabinoid 2‐AG is highly susceptible to its hydrolysis into AA, which activates neutrophils through de novo LTB4 biosynthesis, independently of CB activation. In this study, we show that 2‐AG and AA stimulate neutrophils to release antimicrobial effectors. Supernatants of neutrophils activated with nanomolar concentrations of 2‐AG and AA indeed inhibited the infectivity of HSV‐1 and RSV. Additionally, the supernatants of 2‐AG‐ and AA‐stimulated neutrophils strongly impaired the growth of Escherichia coli and Staphylococcus aureus . This correlated with the release of a large amount (micrograms) of α‐defensins, as well as a limited amount (nanograms) of LL‐37. All the effects of AA and 2‐AG mentioned above were prevented by inhibiting LTB4 biosynthesis or by blocking BLT1 . Importantly, neither CB2 receptor agonists nor antagonists could mimic nor prevent the effects of 2‐AG, respectively. In fact, qPCR data show that contaminating eosinophils express ∼100‐fold more CB2 receptor mRNA than purified neutrophils, suggesting that CB2 receptor expression by human neutrophils is limited and that contaminating eosinophils are likely responsible for the previously documented CB2 expression by freshly isolated human neutrophils. The rapid conversion ofAbstract : Neutrophils activated with nanomolar concentrations of 2‐arachidonoyl‐glycerol or arachidonic acid, release antimicrobial effectors, unraveling these lipids as possible regulators of host defense in vivo. Abstract : The endocannabinoid 2‐AG is highly susceptible to its hydrolysis into AA, which activates neutrophils through de novo LTB4 biosynthesis, independently of CB activation. In this study, we show that 2‐AG and AA stimulate neutrophils to release antimicrobial effectors. Supernatants of neutrophils activated with nanomolar concentrations of 2‐AG and AA indeed inhibited the infectivity of HSV‐1 and RSV. Additionally, the supernatants of 2‐AG‐ and AA‐stimulated neutrophils strongly impaired the growth of Escherichia coli and Staphylococcus aureus . This correlated with the release of a large amount (micrograms) of α‐defensins, as well as a limited amount (nanograms) of LL‐37. All the effects of AA and 2‐AG mentioned above were prevented by inhibiting LTB4 biosynthesis or by blocking BLT1 . Importantly, neither CB2 receptor agonists nor antagonists could mimic nor prevent the effects of 2‐AG, respectively. In fact, qPCR data show that contaminating eosinophils express ∼100‐fold more CB2 receptor mRNA than purified neutrophils, suggesting that CB2 receptor expression by human neutrophils is limited and that contaminating eosinophils are likely responsible for the previously documented CB2 expression by freshly isolated human neutrophils. The rapid conversion of 2‐AG to AA and their subsequent metabolism into LTB4 promote 2‐AG and AA as multifunctional activators of neutrophils, mainly exerting their effects by activating the BLT1 . Considering that nanomolar concentrations of AA or 2‐AG were sufficient to impair viral infectivity, this suggests potential physiological roles for 2‐AG and AA as regulators of host defense in vivo. … (more)
- Is Part Of:
- Journal of leukocyte biology. Volume 93:Issue 2(2013)
- Journal:
- Journal of leukocyte biology
- Issue:
- Volume 93:Issue 2(2013)
- Issue Display:
- Volume 93, Issue 2 (2013)
- Year:
- 2013
- Volume:
- 93
- Issue:
- 2
- Issue Sort Value:
- 2013-0093-0002-0000
- Page Start:
- 267
- Page End:
- 276
- Publication Date:
- 2013-02-01
- Subjects:
- leukotriene -- cannabinoid receptor -- endocannabinoid -- eicosanoid -- GPR55 -- 5‐lipoxygenase
Leucocytes -- Periodicals
Reticulo-endothelial system -- Periodicals
571.96 - Journal URLs:
- http://jlb.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1938-3673/ ↗
https://academic.oup.com/jleukbio ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1189/jlb.0412200 ↗
- Languages:
- English
- ISSNs:
- 0741-5400
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5010.305000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5905.xml